ConductScience.org, home

Paper23754276

UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells.

Brunner R and 22 others. J Biol Chem, 2013. Cited by 18 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells. Papers, record 23754276. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23754276

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
UV-triggered affinity capture identifies interactions between the Plasmodium falciparum multidrug resistance protein 1 (PfMDR1) and antimalarial agents in live parasitized cells.
PubMed
Journal
J Biol Chem
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Validation Study
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.58
iCite
Revised in PubMed
2021-10-21
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brunner RRalf
2Ng CLCaroline L
3Aissaoui HHamed
4Akabas MHMyles H
5Boss CChristoph
6Brun RReto
7Callaghan PSPaul S
8Corminboeuf OOlivier
9Fidock DADavid A
10Frame IJIthiel J
11Heidmann BBibia
12Le Bihan AAmélie
13Jenö PPaul
14Mattheis CCorinna
15Moes SSuzette
16Müller IBIngrid B
17Paguio MMichelle
18Roepe PDPaul D
19Siegrist RRomain
20Voss TTill

Source PubMed

See all 23 authorsDownload CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ATP Binding Cassette Transporter, Subfamily B, Member 1Major topic
AntimalarialsMajor topic
Plasmodium falciparumMajor topic
Ultraviolet RaysMajor topic
Animals

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI056312NIAID NIH HHSUnited StatesR01AI056312PubMed and NIHNIH RePORTER
R01 AI079709NIAID NIH HHSUnited StatesR01AI079709PubMed and NIHNIH RePORTER
T32 GM007288NIGMS NIH HHSUnited StatesT32GM007288PubMed and NIHNIH RePORTER
T32-GM007288NIGMS NIH HHSUnited StatesT32GM007288PubMed and NIHNIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117638538Capture compound mass spectrometry: a technology for the investigation of small molecule protein interactions.Assay Drug Dev Technol2007https://conductscience.org/library/papers/17638538PubMed
220208550Artemisinin resistance: current status and scenarios for containment.Nat Rev Microbiol2010https://conductscience.org/library/papers/20208550PubMed
318439351Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.Emerg Infect Dis2008https://conductscience.org/library/papers/18439351PubMed
422484134Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.Lancet2012https://conductscience.org/library/papers/22484134PubMed
522543Calf liver nuclear N-acetyltransferases. Purification and properties of two enzymes with both spermidine acetyltransferase and histone acetyltransferase activities.J Biol Chem1978https://conductscience.org/library/papers/22543PubMed
621300861Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21300861PubMed
717346175Nucleoside transport as a potential target for chemotherapy in malaria.Curr Pharm Des2007https://conductscience.org/library/papers/17346175PubMed
810861212Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy.Biochem J2000https://conductscience.org/library/papers/10861212PubMed
918669520In vitro assessment of the pharmacodynamic properties of DB75, piperaquine, OZ277 and OZ401 in cultures of Plasmodium falciparum.J Antimicrob Chemother2008https://conductscience.org/library/papers/18669520PubMed
1018567789Purine salvage pathways in the intraerythrocytic malaria parasite Plasmodium falciparum.Eukaryot Cell2008https://conductscience.org/library/papers/18567789PubMed
1121696174Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential.J Med Chem2011https://conductscience.org/library/papers/21696174PubMed
12394674Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/394674PubMed
1322096101Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.Science2011https://conductscience.org/library/papers/22096101PubMed
1424226387An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database.J Am Soc Mass Spectrom1994https://conductscience.org/library/papers/24226387PubMed
1522670848Malaria parasite type 4 equilibrative nucleoside transporters (ENT4) are purine transporters with distinct substrate specificity.Biochem J2012https://conductscience.org/library/papers/22670848PubMed
1622732921Identification of a new chemical class of antimalarials.J Infect Dis2012https://conductscience.org/library/papers/22732921PubMed
1719690537Target profiling of small molecules by chemical proteomics.Nat Chem Biol2009https://conductscience.org/library/papers/19690537PubMed
1817917669Target deconvolution strategies in drug discovery.Nat Rev Drug Discov2007https://conductscience.org/library/papers/17917669PubMed
1918621424A role for membrane potential in regulating GPCRs?Trends Pharmacol Sci2008https://conductscience.org/library/papers/18621424PubMed
2020546803Purified Plasmodium falciparum multi-drug resistance protein (PfMDR 1) binds a high affinity chloroquine analogue.Mol Biochem Parasitol2010https://conductscience.org/library/papers/20546803PubMed

See all 35 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42203772Structural and mechanistic insights into the inhibition of Plasmodium falciparum MDR1.Nat Commun2026https://conductscience.org/library/papers/42203772PubMed
39861091Uncovering the Mechanism of Action of Antiprotozoal Agents: A Survey on Photoaffinity Labeling Strategy.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39861091PubMed
39808111Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug Sensitivity.ACS Infect Dis2025https://conductscience.org/library/papers/39808111PubMed
37232495Chemo-proteomics in antimalarial target identification and engagement.Med Res Rev2023https://conductscience.org/library/papers/37232495PubMed
34765267Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures.J Pharm Anal2021https://conductscience.org/library/papers/34765267PubMed
33570245Chemical Biology Tools To Investigate Malaria Parasites.Chembiochem2021https://conductscience.org/library/papers/33570245PubMed
30108934Recent updates in the discovery and development of novel antimalarial drug candidates.Medchemcomm2018https://conductscience.org/library/papers/30108934PubMed
29637069Targeting Channels and Transporters in Protozoan Parasite Infections.Front Chem2018https://conductscience.org/library/papers/29637069PubMed
28808258Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.Nat Microbiol2017https://conductscience.org/library/papers/28808258PubMed
27701420Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.PLoS Med2016https://conductscience.org/library/papers/27701420PubMed
27073104
CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.
Mol Microbiol2016https://conductscience.org/library/papers/27073104PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23754276

GET https://conductscience.org/api/papers/v1/23754276/authors?page=2